[HTML][HTML] Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review
Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience
S Kure, K Ishino, M Kudo, R Wada… - Journal of …, 2019 - journals.sagepub.com
Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: A meta‐analysis
JH Lee, ES Lee, YS Kim - Cancer, 2007 - Wiley Online Library
BACKGROUND. Numerous studies have investigated the clinical significance of BRAF
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …
BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
C Li, KC Lee, EB Schneider… - The Journal of Clinical …, 2012 - academic.oup.com
Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
[HTML][HTML] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
YS Kim, JS Kim, JS Bae, WC Park - World Journal of Surgical Oncology, 2013 - Springer
Abstract Background The BRAF V600E mutation is the most common genetic alteration in
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …
Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
X Wei, X Wang, J Xiong, C Li, Y Liao… - BioMed Research …, 2022 - Wiley Online Library
Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
[PDF][PDF] The frequency and clinical implications of the BRAFV600E mutation in papillary thyroid cancer patients in Korea over the past two decades
AR Hong, JA Lim, TH Kim, HS Choi… - Endocrinology and …, 2014 - synapse.koreamed.org
Background: Over the past several decades, there has been a rapid worldwide increase in
the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the …
the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the …
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of …
Y Ito, H Yoshida, R Maruo, S Morita, T Takano… - Endocrine …, 2009 - jstage.jst.go.jp
Recent studies have demonstrated that BRAFV600E mutation is a common event in
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …
[HTML][HTML] Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
C Liu, T Chen, Z Liu - World journal of surgical oncology, 2016 - Springer
Background The objective of this study is to perform a meta-analysis to evaluate the
associations between the BRAF V600E mutation status and aggressive clinicopathological …
associations between the BRAF V600E mutation status and aggressive clinicopathological …
Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
Q Zhang, S Liu, Q Zhang, Y Guan, Q Chen… - Cellular Physiology and …, 2016 - karger.com
Abstract Background/Aims: The function of BRAF V600E as a prognostic biomarker
continues controversial by reason of conflicting results in the published articles. Methods: A …
continues controversial by reason of conflicting results in the published articles. Methods: A …
相关搜索
- papillary thyroid carcinoma asian series
- papillary thyroid cancer patients
- brafv600e mutations thyroid carcinoma
- prevalence of brafv600e mutation asian series
- braf v600e thyroid carcinoma
- thyroid cancer higher rate
- prognostic factors thyroid carcinoma
- meta analysis thyroid carcinoma
- clinicopathological features thyroid carcinoma
- clinical implication thyroid carcinoma
- poor outcomes thyroid carcinoma
- thyroid cancer tumor aggressiveness
- japanese population thyroid carcinoma
- papillary carcinomas clinicopathologic significance
- survival of patients thyroid carcinoma
- clinical implications brafv600e mutation